List of works - Esther Titos

5-Lipoxygenase (5-LO) is Involved in Kupffer Cell Survival. Possible Role of 5-LO Products in the Pathogenesis of Liver Fibrosis.

scientific article published on January 2004

5-lipoxygenase deficiency reduces hepatic inflammation and tumor necrosis factor alpha-induced hepatocyte damage in hyperlipidemia-prone ApoE-null mice.

scientific article published on March 2010

5-lipoxygenase inhibition reduces intrahepatic vascular resistance of cirrhotic rat livers: a possible role of cysteinyl-leukotrienes

scientific article published in February 2002

Altered biosynthesis of leukotrienes and lipoxins and host defense disorders in patients with cirrhosis and ascites.

scientific article published in July 1998

Aspirin (ASA) regulates 5-lipoxygenase activity and peroxisome proliferator-activated receptor alpha-mediated CINC-1 release in rat liver cells: novel actions of lipoxin A4 (LXA4) and ASA-triggered 15-epi-LXA4

scientific article (publication date: December 2002)

Aspirin-triggered 15-epi-lipoxin A4 biosynthesis in rat liver cells

scientific article (publication date: 2002)

Atrial natriuretic peptide antagonizes endothelin-induced calcium increase and cell contraction in cultured human hepatic stellate cells

scientific article published on 01 August 1999

Basic mechanisms of hepatocellular injury. Role of inflammatory lipid mediators

scientific article published in December 2008

Gene expression profiling of renal dysfunction in rats with experimental cirrhosis.

scientific article

Hepatocyte-derived cysteinyl leukotrienes modulate vascular tone in experimental cirrhosis

scientific article published on 01 September 2000

Hepatocytes are a rich source of novel aspirin-triggered 15-epi-lipoxin A(4).

scientific article

Implementation of an open-source robotic platform for SARS-CoV-2 testing by real-time RT-PCR

scientific article published in 2021

Increased apoptosis dependent on caspase-3 activity in polymorphonuclear leukocytes from patients with cirrhosis and ascites.

scientific article published in July 2004

Inhibition of 5-lipoxygenase-activating protein abrogates experimental liver injury: role of Kupffer cells.

scientific article published on 20 July 2005

Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: role for omega-3 epoxides

scientific article

New insights into the role of macrophages in adipose tissue inflammation and Fatty liver disease: modulation by endogenous omega-3 Fatty Acid-derived lipid mediators

scientific article published on 5 October 2011

Omega-3-derived mediators counteract obesity-induced adipose tissue inflammation.

scientific article published on 21 May 2013

Pro-resolving mediators produced from EPA and DHA: Overview of the pathways involved and their mechanisms in metabolic syndrome and related liver diseases

scientific article

Protection from hepatic lipid accumulation and inflammation by genetic ablation of 5-lipoxygenase.

scientific article published on 21 March 2010

Rapid identification of single nucleotide polymorphisms by fluorescence-based capillary electrophoresis.

scientific article published on 31 March 2002

Regulatory effects of arachidonate 5-lipoxygenase on hepatic microsomal TG transfer protein activity and VLDL-triglyceride and apoB secretion in obese mice.

scientific article

Renal Effects of Selective Cyclooxygenase Inhibition in Experimental Liver Disease ⬇️

scientific article published on January 1, 2003

Resolution of inflammation in obesity-induced liver disease.

scientific article published on 20 August 2012

Resolvin D1 and Its Precursor Docosahexaenoic Acid Promote Resolution of Adipose Tissue Inflammation by Eliciting Macrophage Polarization toward an M2-Like Phenotype

scientific article published on 17 October 2011

Resolvin D1 primes the resolution process initiated by calorie restriction in obesity-induced steatohepatitis.

scientific article published on 18 November 2013

Role for PPARγ in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts

scientific article published on 19 April 2011

Role of bioactive lipid mediators in obese adipose tissue inflammation and endocrine dysfunction.

scientific article published on 30 September 2015

Selective inhibition of cyclooxygenase 2 spares renal function and prostaglandin synthesis in cirrhotic rats with ascites

scientific article published on 01 May 1999

Short report on DNA markers at candidate loci. Two new polymorphisms in the BRCA 1 gene

scientific article published on 01 May 1997

Signaling and Immunoresolving Actions of Resolvin D1 in Inflamed Human Visceral Adipose Tissue

scientific article

The selective cyclooxygenase-2 inhibitor SC-236 reduces liver fibrosis by mechanisms involving non-parenchymal cell apoptosis and PPARgamma activation.

scientific article published on 4 May 2005

[Kupffer cell]

scientific article published on 01 April 2004

List of works by Esther Titos

5-Lipoxygenase (5-LO) is Involved in Kupffer Cell Survival. Possible Role of 5-LO Products in the Pathogenesis of Liver Fibrosis.

5-lipoxygenase deficiency reduces hepatic inflammation and tumor necrosis factor alpha-induced hepatocyte damage in hyperlipidemia-prone ApoE-null mice.

5-lipoxygenase inhibition reduces intrahepatic vascular resistance of cirrhotic rat livers: a possible role of cysteinyl-leukotrienes

Altered biosynthesis of leukotrienes and lipoxins and host defense disorders in patients with cirrhosis and ascites.

Aspirin (ASA) regulates 5-lipoxygenase activity and peroxisome proliferator-activated receptor alpha-mediated CINC-1 release in rat liver cells: novel actions of lipoxin A4 (LXA4) and ASA-triggered 15-epi-LXA4

Aspirin-triggered 15-epi-lipoxin A4 biosynthesis in rat liver cells

Atrial natriuretic peptide antagonizes endothelin-induced calcium increase and cell contraction in cultured human hepatic stellate cells

Basic mechanisms of hepatocellular injury. Role of inflammatory lipid mediators

Gene expression profiling of renal dysfunction in rats with experimental cirrhosis.

Hepatocyte-derived cysteinyl leukotrienes modulate vascular tone in experimental cirrhosis

Hepatocytes are a rich source of novel aspirin-triggered 15-epi-lipoxin A(4).

Implementation of an open-source robotic platform for SARS-CoV-2 testing by real-time RT-PCR

Increased apoptosis dependent on caspase-3 activity in polymorphonuclear leukocytes from patients with cirrhosis and ascites.

Inhibition of 5-lipoxygenase-activating protein abrogates experimental liver injury: role of Kupffer cells.

Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: role for omega-3 epoxides

New insights into the role of macrophages in adipose tissue inflammation and Fatty liver disease: modulation by endogenous omega-3 Fatty Acid-derived lipid mediators

Omega-3-derived mediators counteract obesity-induced adipose tissue inflammation.

Pro-resolving mediators produced from EPA and DHA: Overview of the pathways involved and their mechanisms in metabolic syndrome and related liver diseases

Protection from hepatic lipid accumulation and inflammation by genetic ablation of 5-lipoxygenase.

Rapid identification of single nucleotide polymorphisms by fluorescence-based capillary electrophoresis.

Regulatory effects of arachidonate 5-lipoxygenase on hepatic microsomal TG transfer protein activity and VLDL-triglyceride and apoB secretion in obese mice.

Renal Effects of Selective Cyclooxygenase Inhibition in Experimental Liver Disease ⬇️

Resolution of inflammation in obesity-induced liver disease.

Resolvin D1 and Its Precursor Docosahexaenoic Acid Promote Resolution of Adipose Tissue Inflammation by Eliciting Macrophage Polarization toward an M2-Like Phenotype

Resolvin D1 primes the resolution process initiated by calorie restriction in obesity-induced steatohepatitis.

Role for PPARγ in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts

Role of bioactive lipid mediators in obese adipose tissue inflammation and endocrine dysfunction.

Selective inhibition of cyclooxygenase 2 spares renal function and prostaglandin synthesis in cirrhotic rats with ascites

Short report on DNA markers at candidate loci. Two new polymorphisms in the BRCA 1 gene

Signaling and Immunoresolving Actions of Resolvin D1 in Inflamed Human Visceral Adipose Tissue

The selective cyclooxygenase-2 inhibitor SC-236 reduces liver fibrosis by mechanisms involving non-parenchymal cell apoptosis and PPARgamma activation.

[Kupffer cell]